Evaluation of current programmed death-ligand 1 (PD-L1) testing practices for metastatic non-small cell lung cancer (mNSCLC): Insights from a large network of US community oncology practices.
Authors: Kathleen M. Aguilar, Jessica Paulus, Ruben GW Quek, TG Hager, Chao Chen, Avi Raju, Malcolm Charles, James Harnett, Paul R. Conkling